JPH101414A - Skin cosmetic - Google Patents
Skin cosmeticInfo
- Publication number
- JPH101414A JPH101414A JP17419096A JP17419096A JPH101414A JP H101414 A JPH101414 A JP H101414A JP 17419096 A JP17419096 A JP 17419096A JP 17419096 A JP17419096 A JP 17419096A JP H101414 A JPH101414 A JP H101414A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- derivatives
- promoting substance
- skin cosmetic
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 30
- 239000000126 substance Substances 0.000 claims abstract description 42
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 23
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 23
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 19
- 102000008186 Collagen Human genes 0.000 claims abstract description 18
- 108010035532 Collagen Proteins 0.000 claims abstract description 18
- 229920001436 collagen Polymers 0.000 claims abstract description 18
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims abstract description 15
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims abstract description 14
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims abstract description 14
- 229940106189 ceramide Drugs 0.000 claims abstract description 14
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims abstract description 14
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims abstract description 14
- 150000003839 salts Chemical class 0.000 claims abstract description 14
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 claims abstract description 12
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 claims abstract description 12
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 10
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 10
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 10
- 210000001339 epidermal cell Anatomy 0.000 claims abstract description 9
- 210000002950 fibroblast Anatomy 0.000 claims abstract description 9
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims abstract description 8
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000012239 silicon dioxide Nutrition 0.000 claims abstract description 7
- MVQVNTPHUGQQHK-UHFFFAOYSA-N 3-pyridinemethanol Chemical compound OCC1=CC=CN=C1 MVQVNTPHUGQQHK-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229960004738 nicotinyl alcohol Drugs 0.000 claims abstract description 5
- 230000001737 promoting effect Effects 0.000 claims description 27
- 238000004519 manufacturing process Methods 0.000 claims description 13
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 10
- 239000000835 fiber Substances 0.000 claims description 5
- 229940083256 peripheral vasodilators nicotinic acid and derivative Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 22
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract description 8
- 235000001968 nicotinic acid Nutrition 0.000 abstract description 4
- 239000011664 nicotinic acid Substances 0.000 abstract description 4
- 229960003512 nicotinic acid Drugs 0.000 abstract description 4
- 230000006870 function Effects 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 230000002452 interceptive effect Effects 0.000 abstract description 2
- 230000004936 stimulating effect Effects 0.000 abstract 2
- 108010009736 Protein Hydrolysates Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 59
- 230000007423 decrease Effects 0.000 description 11
- 239000006210 lotion Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 230000032683 aging Effects 0.000 description 7
- 230000006872 improvement Effects 0.000 description 6
- 230000037303 wrinkles Effects 0.000 description 6
- 102000029816 Collagenase Human genes 0.000 description 5
- 108060005980 Collagenase Proteins 0.000 description 5
- 229960002424 collagenase Drugs 0.000 description 5
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 4
- 206010040844 Skin exfoliation Diseases 0.000 description 4
- -1 ascorbic acid diester Chemical class 0.000 description 4
- 230000035618 desquamation Effects 0.000 description 4
- 239000000686 essence Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 229960001153 serine Drugs 0.000 description 4
- 239000002884 skin cream Substances 0.000 description 4
- 230000007306 turnover Effects 0.000 description 4
- 208000035874 Excoriation Diseases 0.000 description 3
- PSFABYLDRXJYID-UHFFFAOYSA-N N-methyl-DL-serine Natural products CNC(CO)C(O)=O PSFABYLDRXJYID-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000004215 skin function Effects 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- JCBPETKZIGVZRE-UHFFFAOYSA-N 2-aminobutan-1-ol Chemical compound CCC(N)CO JCBPETKZIGVZRE-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- UHOZUUWRLMQQBZ-UHFFFAOYSA-N N,N-Dimethyl-L-serin Natural products CN(C)C(CO)C(O)=O UHOZUUWRLMQQBZ-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000011382 collagen catabolic process Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 108010029690 procollagenase Proteins 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- UHOZUUWRLMQQBZ-BYPYZUCNSA-N (2s)-2-(dimethylamino)-3-hydroxypropanoic acid Chemical compound CN(C)[C@@H](CO)C(O)=O UHOZUUWRLMQQBZ-BYPYZUCNSA-N 0.000 description 1
- PXWASTUQOKUFKY-UHFFFAOYSA-N 2-(methylamino)propan-1-ol Chemical compound CNC(C)CO PXWASTUQOKUFKY-UHFFFAOYSA-N 0.000 description 1
- BKMMTJMQCTUHRP-UHFFFAOYSA-N 2-aminopropan-1-ol Chemical compound CC(N)CO BKMMTJMQCTUHRP-UHFFFAOYSA-N 0.000 description 1
- NZAKDNQAIWGNOG-UHFFFAOYSA-N 2-benzylpyridine-3-carboxylic acid Chemical compound OC(=O)C1=CC=CN=C1CC1=CC=CC=C1 NZAKDNQAIWGNOG-UHFFFAOYSA-N 0.000 description 1
- RESGCFMULOVHHB-UHFFFAOYSA-N 2-ethylpyridine-3-carboxylic acid Chemical compound CCC1=NC=CC=C1C(O)=O RESGCFMULOVHHB-UHFFFAOYSA-N 0.000 description 1
- HNTZKNJGAFJMHQ-UHFFFAOYSA-N 2-methylpyridine-3-carboxylic acid Chemical compound CC1=NC=CC=C1C(O)=O HNTZKNJGAFJMHQ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- PSFABYLDRXJYID-VKHMYHEASA-N N-Methylserine Chemical compound CN[C@@H](CO)C(O)=O PSFABYLDRXJYID-VKHMYHEASA-N 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000004111 Potassium silicate Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229960000839 nicotinyl alcohol tartrate Drugs 0.000 description 1
- NPORIZAYKBQYLF-LREBCSMRSA-N nicotinyl alcohol tartrate Chemical compound OCC1=CC=CN=C1.OC(=O)[C@H](O)[C@@H](O)C(O)=O NPORIZAYKBQYLF-LREBCSMRSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 150000002943 palmitic acids Chemical class 0.000 description 1
- NNHHDJVEYQHLHG-UHFFFAOYSA-N potassium silicate Chemical compound [K+].[K+].[O-][Si]([O-])=O NNHHDJVEYQHLHG-UHFFFAOYSA-N 0.000 description 1
- 229910052913 potassium silicate Inorganic materials 0.000 description 1
- 235000019353 potassium silicate Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 235000019795 sodium metasilicate Nutrition 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- POWFTOSLLWLEBN-UHFFFAOYSA-N tetrasodium;silicate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-][Si]([O-])([O-])[O-] POWFTOSLLWLEBN-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、線維芽細胞コラー
ゲン合成促進物質と線維芽細胞コラゲナーゼ産生促進物
質と表皮細胞セラミド合成促進物質とを含有することを
特徴とする、皮膚機能を亢進させ、皮膚の老化防止効果
(皮膚柔軟化効果、皮膚のはりの改善効果、皮膚のしわ
の改善効果等)に優れた皮膚化粧料に関する。TECHNICAL FIELD The present invention relates to a method for enhancing skin function, comprising a fibroblast collagen synthesis promoting substance, a fibroblast collagenase production promoting substance, and an epidermal cell ceramide synthesis promoting substance. The present invention relates to a skin cosmetic having excellent aging prevention effects (e.g., skin softening effect, skin beam improving effect, skin wrinkle improving effect, etc.).
【0002】[0002]
【従来の技術および発明が解決しようとする課題】老化
した皮膚は、皮膚表面が乾燥し荒れ肌様の状態になる
が、これは角質層の水分保持機能の低下やバリヤー機能
の低下、更に皮脂分泌量の低下等に起因すると考えられ
ている。また、表皮、真皮ともに細胞数の減少を伴い、
代謝機能の低下が生じる。更に、表皮の酸化還元関連の
酵素活性や皮膚の酸素分圧が低下し、角質層のターンオ
ーバー速度が低下することが知られている。一方、皮膚
の大部分の構造を形成する成分として、コラーゲンとエ
ラスチンがあり、皮膚の弾力性と柔軟性を左右している
といわれている。加齢によりこれらの成分の可溶性分画
が減少し、架橋構造が形成され弾力性と柔軟性が低下す
ると考えられている。また、加齢によりコラーゲンの代
謝が低下すると共に、皮膚の細胞間物質であるヒアルロ
ン酸が顕著に減少し、皮膚の水分量の低下を招く。その
結果、老化皮膚は全体的に萎縮して菲薄化した状態にな
り、柔軟性、弾力性や滑かさを失い、荒れた肌となる。2. Description of the Related Art Aged skin has a dry and rough skin-like state, which is caused by a decrease in the water-retaining function of the stratum corneum, a decrease in the barrier function, and a decrease in sebum secretion. It is thought to be due to a decrease in the amount. In addition, both epidermis and dermis are accompanied by a decrease in cell number,
Metabolic function declines. Furthermore, it is known that the activity of redox-related enzymes in the epidermis and the oxygen partial pressure of the skin decrease, and the turnover speed of the stratum corneum decreases. On the other hand, collagen and elastin are components that form most of the structure of the skin, and are said to affect the elasticity and flexibility of the skin. It is thought that the aging decreases the soluble fraction of these components, forms a crosslinked structure, and reduces elasticity and flexibility. In addition, the metabolism of collagen decreases with aging, and hyaluronic acid, which is an intercellular substance of the skin, is significantly reduced, leading to a decrease in the water content of the skin. As a result, the aging skin is generally atrophied and thinned, loses its flexibility, elasticity and smoothness, and becomes rough skin.
【0003】このような老化した皮膚の改善剤として、
コラーゲンやヒアルロン酸を配合した化粧料が数多く提
案されているが、表面の保湿効果が改善されるだけであ
り、本質的に老化肌を改善するものではない。その他、
皮膚細胞賦活剤としてビタミン類や生薬類が使用されて
いるが、やはり老化肌の治療にまでは至っていないのが
現状である。[0003] As an agent for improving such aged skin,
Many cosmetics containing collagen or hyaluronic acid have been proposed, but they only improve the moisturizing effect on the surface and do not essentially improve aging skin. Others
Although vitamins and herbal medicines are used as skin cell activators, the current situation is that the treatment of aging skin has not yet been achieved.
【0004】この様な現状のなか、加齢に伴うコラーゲ
ン代謝回転(一般に、コラーゲンの代謝回転はコラーゲ
ンの分解速度と合成速度により決まる)の低下を食い止
めるために、コラーゲン分解の律速酵素であるコラゲナ
ーゼを増強する方法が考えられ、既に本発明者らによ
り、コラゲナーゼの産生を促進する物質(特許第203
7907号公報、特許第1859690号公報、特開平
6−24935号公報)及びそれらを含有する皮膚化粧
料(特開平4−74106号公報、特開平4−9500
8号公報)などが見出されている。Under these circumstances, collagenase, which is a rate-limiting enzyme for collagen degradation, is used to prevent a decrease in collagen turnover (generally, the turnover of collagen is determined by the rate of collagen degradation and the rate of synthesis) accompanying aging. A method for enhancing collagenase production has already been proposed by the present inventors (Patent No. 203).
7907, JP 1859690, JP-A-6-24935) and skin cosmetics containing them (JP-A-4-74106, JP-A-4-9500)
No. 8) has been found.
【0005】さらに、コラーゲンの合成と分解と言う相
反する作用を同時に促し、より積極的にコラーゲンの代
謝を促進しようという考えに基づいた、アスコルビン酸
またはその誘導体と、コラゲナーゼ産生促進物質とを含
有する皮膚化粧料を、既に本発明者らは見出している
(特開平5−32537号公報)。Further, it contains ascorbic acid or a derivative thereof and a collagenase production-promoting substance based on the idea of simultaneously promoting the opposite actions of synthesis and decomposition of collagen and more positively promoting the metabolism of collagen. The present inventors have already found a skin cosmetic (JP-A-5-32537).
【0006】また、低下した角質層の水分保持機能やバ
リヤー機能を改善するために、皮膚表皮層内部の細胞自
身にセラミド合成を活発化させる方法が考えられ、既に
本発明者らにより、ニコチン酸誘導体等のセラミド合成
促進剤(特願平7−116367号公報)などが見出さ
れている。In order to improve the water retention function and barrier function of the reduced stratum corneum, a method of activating ceramide synthesis in cells in the skin epidermis itself has been considered. Ceramide synthesis accelerators such as derivatives (Japanese Patent Application No. 7-116367) have been found.
【0007】しかし、いずれも皮膚の一部分に着目した
機能改善であるため、皮膚の老化防止効果として未だ十
分とはいえない。[0007] However, since all of these improvements are focused on a part of the skin, they cannot be said to be sufficient as anti-aging effects on the skin.
【0008】かかる背景にあって本発明の目的は、線維
芽細胞のコラーゲン合成を促進する物質とコラゲナーゼ
産生を促進する物質が、互いの作用を妨げることなく働
き、コラーゲンの代謝回転を高めると同時に、表皮細胞
セラミド合成促進物質がセラミド合成を活発化させるこ
とにより、皮膚機能を総合的に亢進させ、皮膚の老化防
止効果(皮膚柔軟化効果、皮膚のはりの改善効果、皮膚
のしわの改善効果等)に優れた皮膚化粧料を提供するこ
とにある。Against this background, an object of the present invention is to provide a substance that promotes collagen synthesis of fibroblasts and a substance that promotes collagenase production without interfering with each other's actions, thereby enhancing collagen turnover. , A ceramide synthesis promoting substance that activates ceramide synthesis enhances skin function comprehensively, preventing skin aging (skin softening effect, skin abrasion improvement effect, skin wrinkle improvement effect) And the like) to provide an excellent skin cosmetic.
【0009】[0009]
【課題を解決するための手段】すなわち、本発明は、
(1)線維芽細胞コラーゲン合成促進物質と線維芽細胞
コラゲナーゼ産生促進物質と表皮細胞セラミド合成促進
物質とを含有することを特徴とする皮膚化粧料、(2)
線維芽細胞コラーゲン合成促進物質が、アスコルビン酸
及びその誘導体からなる群より選ばれる一種又は二種以
上である上記(1)記載の皮膚化粧料、(3)線維芽細
胞コラゲナーゼ産生促進物質が、セリン及びその誘導体
又はエタノールアミン及びその誘導体からなる群より選
ばれる一種又は二種以上である上記(1)から(2)の
いずれかに記載の皮膚化粧料、(4)線維芽細胞コラゲ
ナーゼ産生促進物質が、分子量が500以下の絹繊維の
硫酸加水分解物である上記(1)から(2)のいずれか
に記載の皮膚化粧料、(5)線維芽細胞コラゲナーゼ産
生促進物質が、ケイ酸関連物質及びその塩からなる群よ
り選ばれる一種又は二種以上である上記(1)から
(2)記載のいずれかに皮膚化粧料、(6)表皮細胞セ
ラミド合成促進物質が、ニコチン酸及びその誘導体から
なる群より選ばれる一種又は二種以上である上記(1)
から(5)のいずれかに記載の皮膚化粧料、(7)表皮
細胞セラミド合成促進物質が、ニコチニルアルコール及
びその塩からなる群より選ばれる一種又は二種以上であ
る上記(1)から(5)のいずれかに記載の皮膚化粧料
である。That is, the present invention provides:
(1) A skin cosmetic comprising a fibroblast collagen synthesis promoting substance, a fibroblast collagenase production promoting substance, and an epidermal cell ceramide synthesis promoting substance, (2)
The skin cosmetic composition according to the above (1), wherein the fibroblast collagen synthesis promoting substance is one or more selected from the group consisting of ascorbic acid and derivatives thereof, and (3) the fibroblast collagenase production promoting substance is serine. And (1) a skin cosmetic according to any one of the above (1) to (2), which is one or more selected from the group consisting of ethanolamine and a derivative thereof, and (4) a fibroblast collagenase production promoting substance. Is a sulfuric acid hydrolyzate of silk fiber having a molecular weight of 500 or less, the skin cosmetic according to any one of (1) to (2) above, and (5) a fibroblast collagenase production promoting substance is a silicic acid-related substance. And any one or more of the above-mentioned (1) to (2), which are selected from the group consisting of: One or two or more at which the selected from nicotinic acid and the group consisting of derivatives (1)
To (5), (7) the epidermal cell ceramide synthesis promoting substance is one or more selected from the group consisting of nicotinyl alcohol and salts thereof (1) to (5). The skin cosmetic according to any one of 5).
【0010】[0010]
【発明の実施の形態】以下、本発明の実施の形態を詳述
する。本発明に用いられる線維芽細胞コラーゲン合成促
進物質としては、アスコルビン酸とその塩、アスコルビ
ン酸りん酸エステルおよび硫酸エステルとその塩、アス
コルビン酸モノステアリン酸エステル、アスコルビン酸
モノパルミチン酸エステル、アスコルビン酸ジパルミチ
ン酸エステルなどを挙げることができる。Embodiments of the present invention will be described below in detail. Examples of the fibroblast collagen synthesis promoting substance used in the present invention include ascorbic acid and its salts, ascorbic acid phosphate and sulfate and its salts, ascorbic acid monostearate, ascorbic acid monopalmitate, and ascorbic acid diester. Palmitic acid esters and the like can be mentioned.
【0011】本発明に用いられる線維芽細胞コラーゲン
合成促進物質としてのアスコルビン酸及びその誘導体の
含有量は、本発明の皮膚化粧料の全重量に対して好まし
くは0.01〜10重量%(以下、単に%で示す)であ
る。含有量が0.01%よりも少ないと効果は十分でな
く、10%を越えてもその増量分に見合った効果は期待
できない。The content of ascorbic acid and its derivatives as the fibroblast collagen synthesis promoter used in the present invention is preferably 0.01 to 10% by weight (hereinafter referred to as the total weight of the skin cosmetic of the present invention). , Simply shown as%). If the content is less than 0.01%, the effect is not sufficient, and if it exceeds 10%, the effect corresponding to the increased amount cannot be expected.
【0012】本発明に用いられる線維芽細胞コラゲナー
ゼ産生促進物質としては、プロコラゲナーゼ産生物質
(コラゲナーゼは、前駆体であるプロコラゲナーゼとし
て細胞より分泌され、生体内ではその後、蛋白分解酵素
によってコラゲナーゼに活性化されると考えられてい
る)として一般に知られているもの、例えば、セリン及
びその誘導体、エタノールアミン及びその誘導体、絹部
分水解物、ケイ酸関連物質及びその塩などを挙げること
ができる。[0012] The fibroblast collagenase production promoting substance used in the present invention includes a procollagenase producing substance (collagenase is secreted from cells as a procollagenase which is a precursor. And the like, for example, serine and its derivatives, ethanolamine and its derivatives, partially hydrolyzed silk, silicic acid-related substances and their salts, and the like.
【0013】セリン及びその誘導体としては、例えばL
−セリン、DL−セリン、N−メチル−L−セリン、N
−メチル−DL−セリン、N,N−ジメチル−L−セリ
ン、N,N−ジメチル−DL−セリンなどを挙げること
ができる。[0013] Serine and its derivatives include, for example, L
-Serine, DL-serine, N-methyl-L-serine, N
-Methyl-DL-serine, N, N-dimethyl-L-serine, N, N-dimethyl-DL-serine and the like.
【0014】エタノールアミン及びその誘導体として
は、例えばモノエタノールアミン、N−メチルエタノー
ルアミン、N,N−ジメチルエタノールアミン、2−ア
ミノ−1−ブタノール、2−アミノ−1−プロパノー
ル、N−メチル−2−アミノ−1−ブタノール、N−メ
チル−2−アミノ−1−プロパノールなどを挙げること
ができる。エタノールアミン及びその誘導体は、遊離の
アミンあるいはアミン塩の形で用いられる。アミン塩と
しては、例えば塩酸塩、硫酸塩、硝酸塩、燐酸塩等の鉱
酸の塩、酢酸塩、乳酸塩、クエン酸塩、リンゴ酸塩、酒
石酸塩、フマル酸塩、マレイン酸塩、低級脂肪酸塩、高
級脂肪酸塩等の有機酸の塩などが挙げられる。Examples of ethanolamine and its derivatives include monoethanolamine, N-methylethanolamine, N, N-dimethylethanolamine, 2-amino-1-butanol, 2-amino-1-propanol, N-methyl- Examples thereof include 2-amino-1-butanol and N-methyl-2-amino-1-propanol. Ethanolamine and its derivatives are used in the form of a free amine or an amine salt. Examples of the amine salt include salts of mineral acids such as hydrochloride, sulfate, nitrate and phosphate, acetate, lactate, citrate, malate, tartrate, fumarate, maleate, and lower fatty acids. And salts of organic acids such as salts and higher fatty acid salts.
【0015】絹部分水解物、特に、水溶性絹ペプチドは
皮膚化粧料等に用いられる公知物質であり、例えばその
製造法として特公昭58−17763号公報、特公昭5
9−31520号公報、特公昭60−41043号公報
等が知られている。絹部分水解物の中でも、分子量が5
00以下の絹繊維の硫酸加水分解物が特に好ましいもの
として挙げることができる。[0015] The partially hydrolyzed silk, particularly the water-soluble silk peptide, is a known substance used in skin cosmetics and the like.
No. 9-31520 and Japanese Patent Publication No. 60-41043 are known. Among the partially hydrolyzed silk products, the molecular weight is 5
Sulfuric acid hydrolysates of silk fibers of 00 or less can be mentioned as particularly preferred.
【0016】ケイ酸関連物質及びその塩としては、例え
ば特開平7−188036号公報記載のケイ酸、ケイ酸
カリウム、メタケイ酸ナトリウム、オルトケイ酸ナトリ
ウムなどを挙げることができる。Examples of the silicic acid-related substances and salts thereof include silicic acid, potassium silicate, sodium metasilicate, sodium orthosilicate and the like described in JP-A-7-188036.
【0017】本発明に用いられる線維芽細胞コラゲナー
ゼ産生促進物質の含有量は、その剤形により異なるが、
セリン及びその誘導体、エタノールアミン及びその誘導
体またはケイ酸関連物質及びその塩を用いる場合は、そ
の含有量は本発明の皮膚化粧料の全重量に対して好まし
くは0.001〜10%である。また、絹繊維の硫酸加
水分解物を用いる場合は、絹繊維として0.5〜4%含
む本物質を、本発明の皮膚化粧料の全重量に対して好ま
しくは0.1〜10%である。含有量がその下限よりも
少ないと効果は十分でなく、上限を越えてもその増量分
に見合った効果は期待できない。The content of the fibroblast collagenase production promoting substance used in the present invention varies depending on the dosage form.
When serine and its derivatives, ethanolamine and its derivatives or silicic acid-related substances and their salts are used, their content is preferably 0.001 to 10% based on the total weight of the skin cosmetic of the present invention. When a sulfuric acid hydrolyzate of silk fiber is used, this substance containing 0.5 to 4% as silk fiber is preferably 0.1 to 10% based on the total weight of the skin cosmetic of the present invention. . If the content is less than the lower limit, the effect is not sufficient, and if the content exceeds the upper limit, the effect corresponding to the increased amount cannot be expected.
【0018】本発明に用いられる表皮細胞セラミド合成
促進物質として挙げられるニコチン酸およびその誘導体
としては、ニコチン酸、ニコチン酸アミド、メチルニコ
チン酸、エチルニコチン酸、ベンジルニコチン酸、ニコ
チン酸トコフェロール、クエン酸ニカメタートなどがあ
り、ニコチニルアルコールおよびその塩としては、ニコ
チニルアルコール、酒石酸ニコチニルアルコールなどが
例示される。Nicotinic acid and its derivatives, which are mentioned as the epidermal cell ceramide synthesis promoter used in the present invention, include nicotinic acid, nicotinamide, methylnicotinic acid, ethylnicotinic acid, benzylnicotinic acid, tocopherol nicotinate and citric acid Nicamethate and the like. Examples of nicotinyl alcohol and its salt include nicotinyl alcohol, nicotinyl alcohol tartrate and the like.
【0019】本発明に用いられる表皮細胞セラミド合成
促進物質の含有量は、本発明の皮膚化粧料の全重量に対
して好ましくは0.001〜10%である。含有量がそ
の下限よりも少ないと効果は十分でなく、上限を越えて
もその増量分に見合った効果は期待できない。The content of the epidermal cell ceramide synthesis promoting substance used in the present invention is preferably 0.001 to 10% based on the total weight of the skin cosmetic composition of the present invention. If the content is less than the lower limit, the effect is not sufficient, and if the content exceeds the upper limit, the effect corresponding to the increased amount cannot be expected.
【0020】本発明の皮膚化粧料は、常法に従って、ロ
ーション類、乳液類、クリーム類、軟膏類、パック類、
パウダー類等の剤形にすることが可能である。また、本
発明の皮膚化粧料には、界面活性剤、保湿剤、ph調整
剤、増粘剤、殺菌剤、防腐剤、抗酸化剤、香料、色素、
紫外線吸収剤、顔料等を、本発明の目的を達成する範囲
内で適宜配合することができる。The skin cosmetic composition of the present invention may contain lotions, emulsions, creams, ointments, packs,
It can be made into a dosage form such as powders. Further, the skin cosmetic of the present invention includes a surfactant, a humectant, a ph regulator, a thickener, a bactericide, a preservative, an antioxidant, a fragrance, a pigment,
An ultraviolet absorber, a pigment and the like can be appropriately compounded within a range that achieves the object of the present invention.
【0021】[0021]
【実施例】以下、実施例によって本発明をさらに詳細に
説明する。配合量(%)は重量%を意味する。実施例に
記載の皮膚粘弾性試験、荒れ肌改善効果試験、官能テス
ト(美肌効果試験)は下記の如くである。The present invention will be described in more detail with reference to the following examples. The blending amount (%) means% by weight. The skin viscoelasticity test, rough skin improvement effect test, and sensory test (skin skin effect test) described in the examples are as follows.
【0022】(1)皮膚粘弾性試験 ウィスター系ヘアレスラット(6週齢、オス、1群5
匹)の背部を毛刈りし、右肩の2×2cmの部位に、連
日試料を0.1g塗布した。試験開始後21日目に、塗
布部位および未塗布部位について、特開平4−1552
23号記載の表面粘弾性測定装置を用いて皮膚粘弾性値
を測定し、各群の皮膚粘弾性値の平均値を求めた。尚、
同測定装置により表示される皮膚粘弾性値(任意単位)
は、皮膚がかたい程高い値を示す。(1) Skin viscoelasticity test Wistar hairless rats (6 weeks old, male, group 5)
) Was shaved, and 0.1 g of the sample was applied to a 2 × 2 cm site on the right shoulder every day. On the 21st day after the start of the test, the application site and the non-application site were determined as described in JP-A-4-1552.
The skin viscoelasticity value was measured using a surface viscoelasticity measuring device described in No. 23, and the average value of the skin viscoelasticity values of each group was determined. still,
Skin viscoelasticity value displayed by the measuring device (arbitrary unit)
Indicates that the skin is too hard.
【0023】(2)肌荒れ改善効果試験 下脚に荒れ肌を有する中高年被験者20名を対象として
4週間連続塗布効果を調べた。被験者の左側下脚試験部
位に1日2回約1gの試料を塗布し、試験開始前及び終
了後の皮膚の状態を下記の判定基準により判定した。右
側下脚は試料を塗布せず対照とした。 [皮膚乾燥の判定基準] − :正常 ± :軽微乾燥、落屑なし + :乾燥、落屑軽度 ++ :乾燥、落屑中等度 +++:乾燥、落屑顕著 試験前後の試験部位と対照部位の判定結果を比較し、皮
膚乾燥度が2段階以上改善された場合(例えば+→−,
++→±)を「有効」、1段階改善された場合を「やや
有効」、変化がなかった場合を「無効」とした。試験結
果は「有効」、「やや有効」となった被験者の人数で示
した。(2) Skin roughness improvement effect test The effect of continuous application for four weeks on 20 middle-aged and elderly subjects with rough skin on the lower leg was examined. About 1 g of a sample was applied to the test site of the lower leg of the subject twice a day twice a day, and the skin condition before and after the start of the test was determined according to the following criteria. The lower right leg served as a control without the application of the sample. [Criteria for skin dryness]-: Normal ±: Slightly dry, no desquamation +: Dry, desquamation mild ++: Dry, moderate desquamation +++: Dry, desquamation remarkable Compare the test results before and after test with control site , When the dryness of the skin is improved by two or more steps (for example, + →-,
++ → ±) was regarded as “valid”, the case where the signal was improved by one step was “slightly valid”, and the case where there was no change was “invalid”. The test results were indicated by the number of subjects who became “effective” and “slightly effective”.
【0024】(3)官能テスト(美肌効果試験) 荒れ肌、小皺、乾燥肌等を訴える女性被験者(35〜5
5才)20人に試料を1日2回(朝・夕)連続2ヶ月間
させた後、皮膚の柔軟性、はり、しわの改善について評
価した。結果は、各項目に対して「皮膚の柔軟性が向上
した」「皮膚のはりが改善された」「皮膚のしわが改善
された」と回答した人数で示した。(3) Sensory test (Beauty skin effect test) Female subjects (35 to 5) who complain of rough skin, fine wrinkles, dry skin, etc.
Twenty subjects (5 years old) were allowed to apply the sample twice a day (morning / evening) for two consecutive months, and then evaluated for improvement in skin softness, abrasion, and wrinkles. The results are shown by the number of respondents who answered, "Improved skin flexibility", "Improved skin beam", and "Improved skin wrinkles" for each item.
【0025】実施例1、比較例1,2,3 [スキンクリーム]表1の組成の如く本発明および比較
用のスキンクリームを調製し、前記試験を実施し、その
結果を表2に示した。 (1)組成Example 1, Comparative Examples 1, 2, 3 [Skin Cream] The present invention and comparative skin cream were prepared as shown in Table 1, and the above tests were carried out. The results are shown in Table 2. . (1) Composition
【0026】[0026]
【表1】 [Table 1]
【0027】(2)調製法 成分(C)を約80℃で均一に混合溶解し、約80℃で
均一に混合溶解しておいた成分(A)中に加えて乳化し
た後、約50℃で均一に混合溶解しておいた成分(B)
を添加し、約30℃まで冷却して調製した。 (3)結果(2) Preparation method The component (C) is uniformly mixed and dissolved at about 80 ° C, and the mixture is added to the component (A) which has been uniformly mixed and dissolved at about 80 ° C and emulsified. (B) which was mixed and dissolved uniformly in
And cooled to about 30 ° C. to prepare. (3) Result
【0028】[0028]
【表2】 * 塗布部位の皮膚粘弾性値を、未塗布部位の値を基準(1.0)とした 相対値で示した。[Table 2] * The skin viscoelasticity value of the application site was shown as a relative value with the value of the non-application site as a reference (1.0).
【0029】この表から分る通り、比較例1,2,3の
スキンクリームと比較して実施例1の本発明のスキンク
リームは、諸試験の全てに亘って良好なる結果を示し
た。As can be seen from the table, the skin cream of the present invention of Example 1 showed good results over all the tests in comparison with the skin creams of Comparative Examples 1, 2 and 3.
【0030】実施例2、比較例4,5,6 [スキンローション]表3の組成の如く本発明および比
較用のスキンローションを調製し、前記試験を実施し、
その結果を表4に示した。 (1)組成及び調製法Example 2, Comparative Examples 4, 5, 6 [Skin Lotion] The skin lotion of the present invention and a comparative skin lotion were prepared as shown in Table 3, and the above test was carried out.
Table 4 shows the results. (1) Composition and preparation method
【0031】[0031]
【表3】 [Table 3]
【0032】各成分を混合溶解してローションを調製し
た。 (2)結果Each component was mixed and dissolved to prepare a lotion. (2) Result
【0033】[0033]
【表4】 * 絹晒ノイル10gを40容量%硫酸50mlに浸積し、60で12時間加 熱した後、200mlの冷水を加え一夜室温で放置し、次いで、10N水酸 化ナトリウム溶液を徐々に加えて中和した後、濾過して330mlの上清液 (3%相当のフィブロインを含む)として得たもの。[Table 4] * Immerse 10 g of bleached silk in 50 ml of 40% by volume sulfuric acid, heat at 60 for 12 hours, add 200 ml of cold water, leave at room temperature overnight, and gradually add 10N sodium hydroxide solution to the medium. After summing, the mixture was filtered to obtain 330 ml of a supernatant (containing 3% of fibroin).
【0034】この表から分る通り、比較例4,5,6の
スキンローションと比較して、実施例2の本発明のスキ
ンローションは、諸試験の全てに亘って良好なる結果を
示した。As can be seen from the table, the skin lotion of the present invention of Example 2 showed better results in all of the tests than the skin lotions of Comparative Examples 4, 5, and 6.
【0035】実施例3、比較例7,8,9 [エッセンス]表5,6の組成の如くローションとパウ
ダーからなる用時調製用の本発明のエッセンスを調製
し、使用時に1剤と2剤を適量混合して使用させ、前記
試験を実施し、その結果を表7に示した。 (1)組成及び調製法 1剤:ロ−ションExample 3, Comparative Examples 7, 8, and 9 [Essence] The essence of the present invention comprising a lotion and a powder was prepared as shown in Tables 5 and 6 for use at the time of use. Was used in an appropriate amount, and the test was carried out. The results are shown in Table 7. (1) Composition and preparation method 1 agent: lotion
【0036】[0036]
【表5】 [Table 5]
【0037】各成分を混合溶解してローションを調製し
た。 2剤:パウダーEach component was mixed and dissolved to prepare a lotion. Two agents: powder
【0038】[0038]
【表6】 [Table 6]
【0039】各成分を分散混合してパウダーを調製し
た。 (2)結果Each component was dispersed and mixed to prepare a powder. (2) Result
【0040】[0040]
【表7】 [Table 7]
【0041】この表から分る通り、比較例7,8,9の
エッセンスと比較して、実施例3の本発明のエッセンス
は、諸試験の全てに亘って良好なる結果を示した。As can be seen from the table, the essence of the present invention of Example 3 showed better results in all of the tests than the essences of Comparative Examples 7, 8, and 9.
【0042】以上記載の如く、本発明の皮膚化粧料が皮
膚機能を亢進させ、皮膚の老化防止効果(皮膚柔軟化効
果、皮膚のはりの改善効果、皮膚のしわの改善効果等)
に優れていることは明らかである。As described above, the skin cosmetic composition of the present invention enhances skin function and prevents skin aging (e.g., skin softening effect, skin abrasion improving effect, skin wrinkle improving effect, etc.).
It is clear that it is excellent.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 7/48 A61K 7/48 (72)発明者 井上 紳太郎 神奈川県小田原市寿町5丁目3番28号 鐘 紡株式会社生化学研究所内──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification code Agency reference number FI Technical display location A61K 7/48 A61K 7/48 (72) Inventor Shintaro Inoue 5-3-1 Kotobukicho, Odawara-shi, Kanagawa No. 28 Kanebo Co., Ltd.
Claims (7)
維芽細胞コラゲナーゼ産生促進物質と表皮細胞セラミド
合成促進物質とを含有することを特徴とする皮膚化粧
料。1. A skin cosmetic comprising a fibroblast collagen synthesis promoting substance, a fibroblast collagenase production promoting substance, and an epidermal cell ceramide synthesis promoting substance.
アスコルビン酸及びその誘導体からなる群より選ばれる
一種又は二種以上である請求項1記載の皮膚化粧料。2. A fibroblast collagen synthesis promoting substance,
The skin cosmetic according to claim 1, which is one or more selected from the group consisting of ascorbic acid and derivatives thereof.
が、セリン及びその誘導体又はエタノールアミン及びそ
の誘導体からなる群より選ばれる一種又は二種以上であ
る請求項1から2のいずれかに記載の皮膚化粧料。3. The skin cosmetic according to claim 1, wherein the fibroblast collagenase production promoting substance is one or more selected from the group consisting of serine and its derivatives or ethanolamine and its derivatives. Fees.
が、分子量が500以下の絹繊維の硫酸加水分解物であ
る請求項1から2のいずれかに記載の皮膚化粧料。4. The skin cosmetic according to claim 1, wherein the fibroblast collagenase production promoting substance is a sulfuric acid hydrolyzate of a silk fiber having a molecular weight of 500 or less.
が、ケイ酸関連物質及びその塩からなる群より選ばれる
一種又は二種以上である請求項1から2のいずれかに記
載の皮膚化粧料。5. The skin cosmetic according to claim 1, wherein the fibroblast collagenase production promoting substance is one or more selected from the group consisting of silicic acid-related substances and salts thereof.
チン酸及びその誘導体からなる群より選ばれる一種又は
二種以上である請求項1から5のいずれかに記載の皮膚
化粧料。6. The skin cosmetic according to claim 1, wherein the epidermal cell ceramide synthesis promoting substance is one or two or more selected from the group consisting of nicotinic acid and derivatives thereof.
チニルアルコール及びその塩からなる群より選ばれる一
種又は二種以上である請求項1から5のいずれかに記載
の皮膚化粧料。7. The skin cosmetic according to claim 1, wherein the epidermal cell ceramide synthesis promoting substance is one or more selected from the group consisting of nicotinyl alcohol and salts thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17419096A JPH101414A (en) | 1996-06-12 | 1996-06-12 | Skin cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17419096A JPH101414A (en) | 1996-06-12 | 1996-06-12 | Skin cosmetic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH101414A true JPH101414A (en) | 1998-01-06 |
Family
ID=15974304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17419096A Pending JPH101414A (en) | 1996-06-12 | 1996-06-12 | Skin cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH101414A (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000056326A1 (en) * | 1999-03-24 | 2000-09-28 | La Roche Posay Laboratoire Pharmaceutique | Use of vitamin c or analogues for promoting transformation of inactive procollagen into active collagen |
| WO2001043702A1 (en) * | 1999-12-15 | 2001-06-21 | Kyowa Hakko Kogyo Co., Ltd. | Stabilizers for l-ascorbic acid-2-sodium phosphate |
| WO2004024118A1 (en) * | 2002-09-11 | 2004-03-25 | Kimberly-Clark Worldwide, Inc. | Skin care products |
| FR2859908A1 (en) * | 2003-09-24 | 2005-03-25 | Oreal | COMPOSITION COMPRISING AT LEAST ONE METALLOPROTEINASE INHIBITOR AND AT LEAST ONE MYORELAXANT OR RELAXING AGENT |
| KR100567373B1 (en) * | 1998-12-17 | 2007-03-15 | 주식회사 엘지생활건강 | Liquid Crystal Gel Whitening Cosmetic Composition_ |
| JP2014532675A (en) * | 2011-10-31 | 2014-12-08 | エヴォニク インダストリーズ アーゲー | Cosmetic preparation |
| JP2015509919A (en) * | 2012-01-19 | 2015-04-02 | ザ プロクター アンド ギャンブルカンパニー | Method for smoothing wrinkles and rough skin |
| JP2021100925A (en) * | 2019-10-31 | 2021-07-08 | 共栄化学工業株式会社 | Skin external agent |
| KR20220082876A (en) | 2019-10-15 | 2022-06-17 | 가부시키가이샤 코세 | external skin preparation |
| JP2023118164A (en) * | 2022-02-15 | 2023-08-25 | 株式会社テクノーブル | Skin topical composition |
| CN118059187A (en) * | 2024-02-20 | 2024-05-24 | 广州卓悦生物科技有限公司 | Composition for promoting cell proliferation and application thereof in preparation of cosmetics or medicines |
-
1996
- 1996-06-12 JP JP17419096A patent/JPH101414A/en active Pending
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100567373B1 (en) * | 1998-12-17 | 2007-03-15 | 주식회사 엘지생활건강 | Liquid Crystal Gel Whitening Cosmetic Composition_ |
| FR2791261A1 (en) * | 1999-03-24 | 2000-09-29 | Roche Posay Lab Pharma | USE OF VITAMIN C OR THE LIKE TO PROMOTE THE TRANSFORMATION OF INACTIVE PROCOLLAGENS TO ACTIVE COLLAGENS |
| WO2000056326A1 (en) * | 1999-03-24 | 2000-09-28 | La Roche Posay Laboratoire Pharmaceutique | Use of vitamin c or analogues for promoting transformation of inactive procollagen into active collagen |
| WO2001043702A1 (en) * | 1999-12-15 | 2001-06-21 | Kyowa Hakko Kogyo Co., Ltd. | Stabilizers for l-ascorbic acid-2-sodium phosphate |
| US7419655B2 (en) | 2002-09-11 | 2008-09-02 | Kimberly-Clark Worldwide, Inc. | Skin care products |
| WO2004024118A1 (en) * | 2002-09-11 | 2004-03-25 | Kimberly-Clark Worldwide, Inc. | Skin care products |
| FR2859908A1 (en) * | 2003-09-24 | 2005-03-25 | Oreal | COMPOSITION COMPRISING AT LEAST ONE METALLOPROTEINASE INHIBITOR AND AT LEAST ONE MYORELAXANT OR RELAXING AGENT |
| JP2014532675A (en) * | 2011-10-31 | 2014-12-08 | エヴォニク インダストリーズ アーゲー | Cosmetic preparation |
| JP2015509919A (en) * | 2012-01-19 | 2015-04-02 | ザ プロクター アンド ギャンブルカンパニー | Method for smoothing wrinkles and rough skin |
| JP2017019831A (en) * | 2012-01-19 | 2017-01-26 | ザ プロクター アンド ギャンブル カンパニー | Method for smoothing wrinkles and rough skin |
| KR20220082876A (en) | 2019-10-15 | 2022-06-17 | 가부시키가이샤 코세 | external skin preparation |
| JP2021100925A (en) * | 2019-10-31 | 2021-07-08 | 共栄化学工業株式会社 | Skin external agent |
| JP2023118164A (en) * | 2022-02-15 | 2023-08-25 | 株式会社テクノーブル | Skin topical composition |
| CN118059187A (en) * | 2024-02-20 | 2024-05-24 | 广州卓悦生物科技有限公司 | Composition for promoting cell proliferation and application thereof in preparation of cosmetics or medicines |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2113216C1 (en) | Cosmetic composition (versions) | |
| US9440098B2 (en) | Antiwrinkle composition and age reversal complex | |
| KR100929264B1 (en) | External skin preparation | |
| JP2000103729A (en) | Cosmetic and / or dermatological composition containing hot spring or mineral water and an active agent for combating acne or aging | |
| WO2002015860A1 (en) | Topical antioxidant having vitamin c and method of combination with topical agent by user | |
| JPH0940545A (en) | Stable composition containing ascorbic acid | |
| CN110179687B (en) | Multi-effect repairing polypeptide composition and application thereof in cosmetics | |
| JPH101414A (en) | Skin cosmetic | |
| JP2025083496A (en) | Cosmetic compositions comprising sucrose esters and solvents | |
| JP2000273033A (en) | Gel comprising natural material | |
| JPH101410A (en) | Skin cosmetic | |
| JP5329830B2 (en) | SCF secretion inhibitor and sebum secretion inhibitor | |
| CN111936130B (en) | Topical preparations and treatments containing strontium and methylsulfonylmethane (MSM) | |
| JP2002544154A (en) | Exfoliation method using N-acetylglucoseamine | |
| EP1635779B1 (en) | Cosmetic peeling method using urea | |
| JPH05163132A (en) | Skin cosmetic | |
| JPS6239512A (en) | Cosmetic containing carpronium chloride | |
| CN113318008B (en) | Bath composition and preparation method thereof | |
| JPH05301812A (en) | Skin external preparation | |
| JPH0532537A (en) | Skin cosmetic | |
| JP2002338426A (en) | Exfoliating agent | |
| Lipozenčić et al. | Moisturizers | |
| US6447789B1 (en) | Facial cleanser and method of treating skin conditions | |
| JP3205601B2 (en) | Hair restorer | |
| JP3532713B2 (en) | Skin cosmetics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A02 | Decision of refusal |
Effective date: 20040323 Free format text: JAPANESE INTERMEDIATE CODE: A02 |